Peter Vonu, MD
Plastic Surgery · Newport News, VANPI 1881793669
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Musculoskeletal Transplant Foundation Inc. at 27.5% of the total. 2025 is the largest year on record at $960, 2.5 times the $382 reported in 2019.
Across 84 payments — averaging $42.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$985
- Polynovo North America LLC$912
- Mentor Worldwide LLC$716
- AbbVie$651
- Galderma Laboratories, L.p.$61
- Sientra, Inc.$47
- plus $211 from 7 others
Across 7 payments — averaging $821.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mentor Worldwide LLC$4K
- Medical Device Business Services, Inc.$2K
What the payments were for
- Food & beverage$3,583100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 9 | $985 |
| Polynovo North America LLC | 14 | $912 |
| Mentor Worldwide LLC | 26 | $716 |
| AbbVie(2 entities) | 20 | $651 |
| Galderma Laboratories, L.p. | 4 | $61 |
| Sientra, Inc. | 3 | $47 |
| Johnson & Johnson | 1 | $45 |
| TELA Bio, Inc. | 1 | $35 |
| Medtronic | 1 | $33 |
| Endo Pharmaceuticals Inc. | 2 | $29 |
| Davol Inc. | 1 | $28 |
| Integra Lifesciences Corporation | 1 | $22 |
| Motiva USA, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,583 in reported general payments places this provider in the 55th percentile of 121 plastic surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $154 |
| Cephalexin | 11 | $68 |
| Ondansetron OdtOndansetron | 12 | $40 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Newport News
- Michael CohenNewport News$15K
- Michael LofgrenNewport News$9K
- Ali MesbahiMcLean$277K
- Vineet MehanFalls Church$244K
- Michael GrantCharlottesville$145K
- Anne NickodemVienna$117K
- Christopher CampbellCharlottesville$69K
- Eva DentchevaNorfolk$54K
- Richard RosenblumVirginia Beach$39K
- Reps SundinRichmond$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.